Potential impact of benzodiazepine use on the rate of hip fractures in five large European countries and the United States.

Calcified Tissue International
T P KhongH Petri

Abstract

Benzodiazepine use increases the risk of falls and has been associated with an increased risk of hip fractures. Our aim was to estimate the possible population impact of the use of benzodiazepines on the rate of hip fracture in France, Germany, Italy, Spain, the United Kingdom, and the United States. We conducted a literature review to estimate the pooled relative risk (RR) for hip fractures and use of benzodiazepines. Prevalence rates of benzodiazepine use in 2009 were calculated for each country using the IMS MIDAS database and three public databases in Denmark, the Netherlands, and Norway. Both the RR and prevalence rates were used for calculation of population attributable risks (PARs) of hip fractures associated with benzodiazepine use. The literature review showed an increased risk of hip fractures in benzodiazepine users (RR = 1.4, 95 % CI 1.2-1.6). Rate of benzodiazepine use showed considerable differences between countries, ranging from 4.7 % to 22.3 % of population ever in a 1-year period. These are reflected in results for the PARs; estimated attributions of benzodiazepines to the rate of hip fractures were 1.8 %, 95 % CI 1.1-2.6 (Germany); 2.0 %, 95 % CI 1.2-2.8 (United Kingdom); 5.2 %, 95 % CI 3.2-7.3 (Italy); 7.4 ...Continue Reading

References

Dec 15, 1989·JAMA : the Journal of the American Medical Association·W A RayW Downey
Feb 12, 1987·The New England Journal of Medicine·W A RayL J Melton
Mar 23, 1995·The New England Journal of Medicine·S R CummingsT M Vogt
Jul 1, 1994·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·S R CummingsK G Faulkner
Nov 1, 1994·American Journal of Epidemiology·M J LichtensteinW A Ray
Mar 15, 1993·The Medical Journal of Australia·R G Cumming, R J Klineberg
Jul 2, 1997·JAMA : the Journal of the American Medical Association·B HemmelgarnG Pinard
Jan 1, 1997·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·B GullbergJ A Kanis
Mar 12, 1998·Journal of Clinical Epidemiology·M M OhayonC Guilleminault
Jan 27, 1999·Journal of the American Geriatrics Society·R M LeipzigM E Tinetti
May 29, 1999·Acta Neurologica Scandinavica·P VestergaardL Mosekilde
Jun 28, 2001·Medicine and Science in Sports and Exercise·C A Macera, K E Powell
Feb 15, 2002·Journal of the American Geriatrics Society·P S WangJ Avorn
Apr 30, 2003·Archives of Internal Medicine·Kristine E EnsrudUNKNOWN Study of Osteoporotic Fractures Research Group
Aug 19, 2003·CNS Drugs·Robert G Cumming, David G Le Couteur
Sep 6, 2003·BMJ : British Medical Journal·Julian P T HigginsDouglas G Altman
Feb 11, 2004·Joint, Bone, Spine : Revue Du Rhumatisme·Pascal Lefauveau, Patrice Fardellone
Jul 16, 2004·Heart·P JepsenH T Sørensen
Jul 28, 2004·Archives of Internal Medicine·Anita K WagnerDennis Ross-Degnan
Sep 15, 2004·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·Olof Johnell, John Kanis
Sep 28, 2004·European Journal of Clinical Pharmacology·Arcangelo CiunaCorrado Barbui
Dec 25, 2004·European Journal of Clinical Pharmacology·P D KnoesterY A Hekster
Oct 26, 2005·Drugs & Aging·Dustin D FrenchPhilip Foulis
Jun 23, 2006·Journal of Internal Medicine·P VestergaardL Mosekilde
Jul 14, 2006·BMC Medical Research Methodology·Mandy HildebrandtMaria Blettner
Aug 11, 2007·International Clinical Psychopharmacology·Sylvie PetitjeanGerhard A Wiesbeck
Sep 14, 2007·Kidney International·W C WinkelmayerP S Wang
Jan 5, 2008·Handbook of Experimental Pharmacology·K T Olkkola, J Ahonen
Aug 2, 2008·The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry·Chia-Ming ChangKeh-Ming Lin
Apr 17, 2009·The Cochrane Database of Systematic Reviews·Jill FerrariTrevor D Prior
Apr 30, 2009·Pharmacoepidemiology and Drug Safety·Svein R KjosavikSteinar Hunskaar
Feb 26, 2010·Japanese Journal of Radiology·Nobuo TomizawaKuni Ohtomo
Mar 30, 2010·Journal of the American Geriatrics Society·Richard G CrillyLizebeth Cox
May 28, 2010·Diabetes Research and Clinical Practice·Wenying YangPhilip D Home
Aug 31, 2010·Pharmacy World & Science : PWS·Merethe Omdal AmundsenHedvig Nordeng

❮ Previous
Next ❯

Citations

Nov 26, 2013·Zeitschrift für Gerontologie und Geriatrie·W Hofmann
Dec 11, 2013·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·R AzagraE M Dennison
May 9, 2014·European Journal of Clinical Pharmacology·Marit Stordal BakkenSabine Ruths
May 31, 2014·International Journal of Public Health·Pili FerrerLuisa Ibáñez
Jun 15, 2014·Age and Ageing·Felicity C VealGregory M Peterson
Sep 10, 2013·Pain Medicine : the Official Journal of the American Academy of Pain Medicine·Gary M Reisfield, Lynn R Webster
Jul 18, 2015·Pharmacoepidemiology and Drug Safety·Johanna H M DriessenAndrea M Burden
Mar 6, 2016·European Journal of Clinical Pharmacology·Xavier VidalUNKNOWN Potentially Inappropriate Prescription in Older Patients in Spain (PIPOPS) Investigators’ project
Apr 3, 2016·Pharmacoepidemiology and Drug Safety·Robert F ReynoldsOlaf H Klungel
Apr 16, 2016·American Journal of Preventive Medicine·Catherine S HwangJana K McAninch
Dec 17, 2014·The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry·Isabelle CarrièreMarie Laure Ancelin
Nov 17, 2016·Journal of the American Medical Directors Association·Laura SaarelainenHeidi Taipale
Jan 30, 2016·The British Journal of General Practice : the Journal of the Royal College of General Practitioners·Caterina VicensAlfonso Leiva
Jul 25, 2019·PloS One·Cláudia TótoliMaria Eugênia F Canziani
Jul 25, 2019·European Journal of Clinical Pharmacology·Encarnación Blanco-ReinaInmaculada Bellido-Estévez
Apr 25, 2017·Scoliosis and Spinal Disorders·Arnold Yl WongDino Samartzis
Jan 23, 2016·Pharmacoepidemiology and Drug Safety·Joan-Ramon Laporte
Dec 11, 2019·International Journal of Clinical Pharmacy·Stanislava JankyovaTatiana Foltanova
Mar 4, 2017·International Journal of Clinical Pharmacy·László HorváthIstván Fekete
Dec 20, 2014·Postgraduate Medicine·Lynn R WebsterNabarun Dasgupta
Feb 13, 2020·Deutsches Ärzteblatt International·Sven ButhUwe Verthein
May 6, 2021·The British Journal of General Practice : the Journal of the Royal College of General Practitioners·Mumtaz BegumNigel Stocks

❮ Previous
Next ❯

Software Mentioned

IMI PROTECT
PROTECT
Cochrane Review Manager
IMS MIDAS

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.